Your letter to the FDA was valuable at the November 2019 hearings (on mercury amalgam) – a pharmacist who has intensely studied pharmacology. I was the one who stood and read it into the record.
Charles G. Brown
National Counsel, Consumers for Dental Choice
Discover more from The Wellness By Design Project
Subscribe to get the latest posts sent to your email.